# COMAR 10.09.14.05: COMAR 10.09.14.05. Limitations

> Maryland · Regulations · In force

URL: https://www.frixlaw.com/law-library/statutes/STATE_MD_COMAR_10_09_14_05

## Section

- **Citation:** COMAR 10.09.14.05
- **Heading:** COMAR 10.09.14.05. Limitations
- **Jurisdiction:** Maryland
- **Kind:** Regulations
- **Status:** In force
- **Text as of:** August 14, 2026
- **Source:** Compiled text
- **Location:** Code of Maryland Regulations / Title 10 MARYLAND DEPARTMENT OF HEALTH / Subtitle 09 MEDICAL CARE PROGRAMS / Chapter 14 Vision Care Services / COMAR 10.09.14.05

## Text

A. The following are not covered:
(1) Eyeglasses, ophthalmic lenses, optical aids, and optician services rendered to recipients 21 years old and older;
(2) Eyeglasses, ophthalmic lenses, optical aids, and optician services rendered to recipients which were not ordered as a result of a full or partial EPSDT screen;
(3) Repairs, except when repairs to eyeglasses are more cost-effective than replacing with new eyeglasses;
(4) Combination or metal frames except when required for proper fit;
(5) Cost of travel by the provider;
(6) A general screening of a Medical Assistance population;
(7) Visual training sessions which do not include orthoptic treatment;
(8) Routine adjustment.
B. An optometrist certified by the Board as qualified to administer diagnostic pharmaceutical agents may use the following agents in strengths not greater than the strengths indicated:
(1) Agents directly or indirectly affecting the pupil of the eye, including the mydriatics and cycloplegics listed below:
(a) Phenylephrine hydrochloride (2.5 percent);
(b) Hydroxyamphetamine hydrobromide (1 percent);
(c) Cyclopentolate hydrochloride (0.5—2 percent);
(d) Tropicamide (0.5 and 1 percent);
(e) Cyclopentolate hydrochloride (0.2 percent) with Phenylephrine hydrochloride (1 percent);
(f) Dapiprazole hydrochloride (0.5 percent); and
(g) Hydroxyamphetamine hydrobromide (1 percent) and Tropicamide (0.25 percent); and
(2) Agents directly or indirectly affecting the sensitivity of the cornea including the:
(a) Topical anesthetics listed below:
(i) Proparacaine hydrochloride (0.5 percent); and
(ii) Tetracaine hydrochloride (0.5 percent); and
(b) Diagnostic topical anesthetic and dye combinations listed below:
de (0.5 percent); and
(g) Hydroxyamphetamine hydrobromide (1 percent) and Tropicamide (0.25 percent); and
(2) Agents directly or indirectly affecting the sensitivity of the cornea including the:
(a) Topical anesthetics listed below:
(i) Proparacaine hydrochloride (0.5 percent); and
(ii) Tetracaine hydrochloride (0.5 percent); and
(b) Diagnostic topical anesthetic and dye combinations listed below:
(i) Benoxinate hydrochloride (0.4 percent) — Fluorescein sodium (0.25 percent); and
(ii) Proparacaine hydrochloride (0.5 percent) — Fluorescein sodium (0.25 percent).
C. An optometrist certified by the Board as qualified to administer and prescribe topical therapeutic pharmaceutical agents is limited to:
(1) Ocular antihistamines, decongestants, and combinations of them, excluding steroids;
(2) Ocular antiallergy pharmaceutical agents;
(3) Ocular antibiotics and combinations of ocular antibiotics, excluding specially formulated or fortified antibiotics;
(4) Anti-inflammatory agents, excluding steroids;
(5) Ocular lubricants and artificial tears;
(6) Tropicamide;
(7) Homatropine;
(8) Nonprescription drugs that are commercially available; and
(9) Primary open-angle glaucoma medications, in accordance with a written treatment plan developed jointly between the optometrist and an ophthalmologist.

## Nearby sections

- [COMAR 10.09.14.01 COMAR 10.09.14.01. Definitions](https://www.frixlaw.com/law-library/statutes/STATE_MD_COMAR_10_09_14_01.md)
- [COMAR 10.09.14.02 COMAR 10.09.14.02. License Requirements](https://www.frixlaw.com/law-library/statutes/STATE_MD_COMAR_10_09_14_02.md)
- [COMAR 10.09.14.03 COMAR 10.09.14.03. Conditions for Participation](https://www.frixlaw.com/law-library/statutes/STATE_MD_COMAR_10_09_14_03.md)
- [COMAR 10.09.14.04 COMAR 10.09.14.04. Covered Services](https://www.frixlaw.com/law-library/statutes/STATE_MD_COMAR_10_09_14_04.md)
- [COMAR 10.09.14.05 COMAR 10.09.14.05. Limitations](https://www.frixlaw.com/law-library/statutes/STATE_MD_COMAR_10_09_14_05.md)
- [COMAR 10.09.14.06 COMAR 10.09.14.06. Preauthorization Requirements](https://www.frixlaw.com/law-library/statutes/STATE_MD_COMAR_10_09_14_06.md)
- [COMAR 10.09.14.07 COMAR 10.09.14.07. Payment Procedures](https://www.frixlaw.com/law-library/statutes/STATE_MD_COMAR_10_09_14_07.md)
- [COMAR 10.09.14.08 COMAR 10.09.14.08. Recovery and Reimbursement](https://www.frixlaw.com/law-library/statutes/STATE_MD_COMAR_10_09_14_08.md)
- [COMAR 10.09.14.09 COMAR 10.09.14.09. Cause for Suspension or Removal and Imposition of Sanctions](https://www.frixlaw.com/law-library/statutes/STATE_MD_COMAR_10_09_14_09.md)
- [COMAR 10.09.14.10 COMAR 10.09.14.10. Appeal Procedures](https://www.frixlaw.com/law-library/statutes/STATE_MD_COMAR_10_09_14_10.md)
- [COMAR 10.09.14.11 COMAR 10.09.14.11. Interpretive Regulation](https://www.frixlaw.com/law-library/statutes/STATE_MD_COMAR_10_09_14_11.md)

---

Source: Frix Law Library, https://www.frixlaw.com/law-library/statutes/STATE_MD_COMAR_10_09_14_05. Check the current official text before relying on it. Not legal advice.
